Delivery Order SPE2DR25D1109-SPE2DR26FFG0C
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Quillichew ER 30 mg chew tablets (100 count) with a ceiling value of $2,031.26 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units) with a contract value of $8,334.51. This is a firm fixed-price delivery order with an ultimate completion date of October 15, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units) with a ceiling value of $3,172.60. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order with an ultimate completion date of August 26, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $1,904.32 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chewable tablets (100-count units). The contract, awarded on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed-price, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,045.00 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This competitively awarded, firm fixed-price contract requires performance at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Quillichew ER 40 mg chew tablets (100-count units) with a firm fixed price ceiling value of $2,420.40. This is a non-set-aside, competitively awarded contract with an ultimate completion date of October 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Quillichew ER 20 mg chew tablets (100-count units) valued at $1,010.70. This firm fixed-price delivery order, with an ultimate completion date of October 30, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award carries no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a $1,047.54 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Quillichew ER 40 mg chewable tablets (100-count units). This firm fixed price, competitively awarded contract utilizes no set-aside designation and is scheduled for completion by October 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a $5,852.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Quillichew ER 30 mg chew tablets in quantities of 100. The delivery order, which represents a child contract under a larger vehicle, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This award was competitively awarded with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Quillichew ER 20 mg chew tablets (100-count units) with a ceiling value of $1,043.96. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The contract represents a routine pharmaceutical procurement supporting...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFG0CDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Quillichew ER 30 mg chew tablets (100 count) with a ceiling value of $1,928.13. This competitively awarded, firm fixed-price delivery order is not associated with a set-aside designation and is scheduled for ultimate completion by November 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen is a critical federal vendor for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The delivery order demonstrates the company's ongoing role as a strategic supplier to the Defense Health Agency and other federal healthcare systems through flexible procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/4/25 |